AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
TARRYTOWN, N.Y. -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast discussions on two panels on which members of its senior management team will participate at the RBC Capital Conference on December 14, 2006.
George D. Yancopoulos, M.D., Ph.D., President of Regeneron Research Laboratories and Chief Scientific Officer of Regeneron, will participate on the New Antibody Technology panel on December 14 at 1:00 pm (ET). Neil Stahl, Ph.D., Senior Vice President, Therapeutics and Clinical Program Development, will participate on the Eyeing the Future of AMD panel on December 14 at 11:00 am (ET). The panel discussions will be broadcast live and may be accessed through the Company's website (www.regeneron.com on the Events page, under the Investor ...
Source: HighBeam Research, Regeneron Announces Participation In Panel Discussions At RBC Capital...